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Abstract
Studies of leukocyte telomere length (LTL) and adiposity have produced conflicting results, and the relationship between
body mass index (BMI) and telomere length throughout life remains unclear. We therefore tested association of adult LTL
measured in 5,598 participants with: i) childhood growth measures (BMI and age at adiposity rebound (AR)); ii) change in
BMI from childhood to adulthood and iii) adult BMI, waist-to-hip ratio (WHR), body adiposity index (BAI). Childhood BMI at
AR was positively associated with LTL at 31 years in women (P= 0.041). Adult BMI and WHR in both men (P= 0.025 and
P= 0.049, respectively) and women (P= 0.029 and P= 0.008, respectively), and BAI in women (P= 0.021) were inversely
associated with LTL at 31 years. An increase in standardised BMI between early childhood and adulthood was associated
with shorter adult LTL in women (P= 0.008). We show that LTL is inversely associated with multiple measures of adiposity in
both men and women. Additionally, BMI increase in women from childhood to adulthood is associated with shorter
telomeres at age 31, potentially indicating accelerated biological ageing.
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Introduction
Telomeres are protective DNA-protein structures that cap the
ends of linear chromosomes, extending to 10–15 kb in humans. In
proliferative tissues such as leukocytes, telomeres shorten with each
cell division – a process believed to be accelerated by oxidative
stress and inflammation [1–3]. Mean leukocyte telomere length
(LTL) in adulthood is influenced by genetic factors [4], and
multiple environmental exposures including chronic psychological
stress [5], childhood adversities [6,7] and lifestyle factors such as
smoking [8]. LTL is positively correlated with human lifespan [9],
while shorter LTL is associated with several age-related conditions
including type 2 diabetes (T2D), heart disease and some cancers
[10–13]. LTL has thus been proposed as a biomarker of biological
ageing, though further longitudinal studies are required to confirm
this hypothesis [14,15].
Inverse associations between telomere length and body mass
index (BMI), waist-to-hip ratio (WHR), waist circumference and
visceral fat in adulthood have been reported [16–20]. However,
other studies have indicated a lack of association with these
adiposity-related phenotypes (reviewed in [21]). Furthermore, the
relationship between telomere length and body adiposity index
(BAI, calculated as (hip circumference (cm))/((height(m))1.5)218)
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has not been investigated, despite assertions that this anthropo-
metric measure may be a better index of body fat than BMI [22].
One explanation for the conflicting results for associations between
LTL and measures of adiposity could be sample diversity both
within and between studies, in particular the inclusion of wide age-
ranges and uneven sex distributions. Indeed, one study reports a
stronger inverse association between BMI and LTL in young (,
30 years) compared to older (.60 years) women [16], suggesting
that the relationship between obesity and telomere length may
change throughout life. In recognition of these inconsistencies in
the current literature, a recent review and meta-analysis of
previous studies of telomere length and BMI called for further
large-scale epidemiological studies in different age groups and
sexes, ideally including additional measures of adiposity [23]. Our
objective was to address this gap in research.
With regard to childhood obesity, we previously carried out a
case-control study in a cohort aged 2–17 years. This analysis
revealed that severely obese children have shorter white blood cell
telomeres in childhood than their normal weight peers [24].
However, to our knowledge, no workers have investigated whether
childhood BMI, or the increase in BMI from childhood to
adulthood, is associated with telomere length in adulthood. Given
the rising prevalence of both child and adult obesity worldwide,
and the potential increased risk of age-related conditions such as
T2D and cardiovascular disease that is associated with excess or
abnormal fat accumulation, these are key issues to address [25,26].
The biological mechanisms that may underlie associations
between shorter LTL and increased BMI are currently unknown,
although obesity is recognised as a state of both increased oxidative
stress and low-grade inflammation: both processes that are
believed to accelerate leukocyte telomere attrition [1–3].
In the present study, we aimed to investigate the relationship
between telomere length and adiposity using a longitudinal design,
making use of prospectively gathered data from the Northern
Finland Birth Cohort 1966 (NFBC 1966). We used childhood
growth data to model age and BMI at adiposity rebound (AR), i.e.
the point at which BMI reaches its nadir in early childhood
(,5 years). Early AR has been shown to predict increased
adiposity in adolescence [27] and may also be related to poorer
metabolic health in adulthood [28]. Using anthropometric and
telomere measurement data obtained for 5,598 participants aged
31 (48% male), our aims were threefold:
i) To investigate the association between age/BMI at AR in
childhood and LTL at age 31;
ii) To investigate the association between longitudinal change in
BMI from childhood (,5 years) to age 31 and LTL;
iii) To test the association between WHR, BMI, BAI and LTL at
age 31.
Materials and Methods
Study Samples
Pregnant women living in the provinces of Oulu and Lapland
with expected delivery dates in 1966 were invited to participate in
the NFBC1966, a prospective follow-up study from birth into
adulthood [29] (Figure 1). A total of 12,058 live-born children
(6,169 boys and 5,889 girls) were enrolled in the study; 96.3% of
all births in the region. Detailed information on participants at
birth, including mother’s parity and parents’ socio-economic status
(SES), was collected using questionnaires at hospitals or by trained
nurses. Childhood growth measurements were obtained by trained
nurses from birth to 16 years of age. At age 31 years, all those alive
and with known address were traced (N = 11,541) and sent postal
questionnaires, from which information including participant’s
children, SES, smoking status and age at menarche was obtained.
For this study, smoking status at 31 years was defined as either
non/light (,10 cigarettes per day) or heavy (.10 cigarettes per
day), since there was no significant difference between the mean
telomere length of non-smokers and light smokers (data not
shown). A subset of 8,463 living in the original target area or in the
Helsinki area were also invited to a clinical examination, in which
6,007 consenting participants took part [30]. Blood samples were
taken at that time, from which 5,753 DNA samples were
successfully extracted. LTL measurements were obtained for
5,620 of these individuals, of which 22 extreme values were
excluded (see below), leaving 5,598 for use in analyses.
Ethics Statement
Informed written consent for the use of the data and DNA was
obtained from all subjects, and approval granted by the Ethics
Committee of the Northern Ostrobothnia Hospital District in
Oulu (Finland).
Childhood Anthropometric Measurements
For each individual, predicted age and BMI at AR were
calculated using sex-specific polynomial mixed effects models,
fitted on BMI measurements collected longitudinally from
18 months to 13 years of age, with the mid-point at 7.25 years.
A natural logarithmic transformation of BMI was used to reduce
skewness. A detailed description of model selection and fit is given
elsewhere [31]. The main model used was as follows: In (BMI (kg/
m2)) = b0+ b1 Age + b2 Age2+ b3 Age3+ b4 Sex + b5 Age * Sex +
b6 Age
2 * Sex + u0+ u1 (Age) + e.
The b0, b1, b2, b3, b4, b5 and b6 are the fixed effects, u0 and u1
are the individual level random effects and e is the residual error.
Age at AR was defined as the age when BMI measurement
reached its minimum, between 2.5 and 8.5 years, with cut-off
points chosen from descriptive analysis of growth curves. Each
individual’s data were weighted by the number of measurements
within the age window to account for uncertainty in the derived
parameters. Individuals with fewer than three measurements were
excluded from the analysis, as were multiple births.
Adulthood Anthropometric Measurements
BMI at 31 years was calculated from weight and height
measurements using the formula weight/height2 (kg/m2). Individ-
uals with a BMI,18.5 were defined as underweight, those with a
BMI.18.5,25.0 were defined as normal weight, those with a
BMI.25.0 were defined as overweight and those with a BMI.
30.0 were defined as obese [32].
WHR was calculated from waist and hip measurements taken at
age 31 years. BAI at 31 years was calculated as described by
Bergman et al [25], as (hip circumference (cm))/((height(m))1.5) 2
18) (Table 1).
Longitudinal Change in BMI
Firstly, values for z-score BMI at AR in childhood and z-score
BMI at 31 years were calculated separately in males and females,
standardised to zero mean and unit variance. The change in z-score
BMI was then calculated as the difference between these two
measurements: ((BMI z-score at 31) 2 (BMI z-score at AR)). The
resulting variable, BMI z-score change, provides a sex-specific
measure of the standardised increase in BMI from childhood to
adulthood for each participant.
Adiposity and Telomere Length
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Figure 1. Flow chart for inclusion of study participants.
doi:10.1371/journal.pone.0099133.g001
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Leukocyte Telomere Length (LTL) Measurements
Mean relative LTL was measured in genomic DNA samples
prepared from peripheral blood leukocytes taken at age 31, using a
multiplex quantitative real-time PCR method [33], with minor
modifications as described previously [24]. Briefly, the multiplex
qPCR method for measuring mean relative telomere length
provides a ‘‘T/S ratio’’ for each DNA sample. This is a relative
measure of the amplification of the telomeric DNA sequence (T)
compared to that of a single copy gene (S) in each test sample,
normalised using a common reference DNA sample. The mean R2
values for the calibration curves, based on values obtained for
serial dilutions of the reference sample spanning 5–50 ng and run
in triplicate, were 0.94 (SD = 0.02) and 0.96 (SD = 0.01) for the T
and S amplicons respectively.
The overall mean coefficient of variation (CV) for T/S values of
duplicate test samples on the same plate was 5%, and the mean
inter-run CV for selected samples was 6.2%.
Exclusions and Sample Sizes
Individuals with extreme BMI values (BMI.50 kg/m2 or a
BMI z-score change .3 standard deviations from the sex-stratified
population means, N = 102) were excluded to reduce risk of
misclassification due to measurement or data entry errors.
Additionally, samples with extreme LTL values were excluded
from the analysis (.3 standard deviations from the overall
population mean, N = 22). This relatively conservative cut-off
was chosen to minimise potential uncertainty about the validity of
extreme telomere length values obtained using qPCR [34]. The
final number of participants investigated in each part of the study,
after exclusions and taking account of all available data, is shown
in Figure 1. In summary, of the N = 5,753 participants who
participated in the clinical examination at age 31 and had DNA
samples available, three datasets were selected for analysis. 1)
individuals with telomere measurements at 31 years and childhood
BMI measurements at AR, N = 3,903; 2) individuals with telomere
measurements at 31 years and adult BMI measurements (at 31
years), N = 5,404; and 3) individuals with telomere measurements
at 31 years and BMI z-score change (age at AR to 31 years),
N = 3,683. The samples used for analysis were representative of
the NFBC1966 subjects for these parameters and there were no
differences observed between the complete dataset and incomplete
datasets (P.0.05).
Statistical Analyses
Descriptive characteristics of the study samples were determined
overall and for men and women separately (Table 1). Means with
standard deviation (SD) were calculated for continuous variables,
and percentages were calculated for categorical variables, as well
as for individuals classed as underweight, normal weight,
overweight and obese. Student’s t-test for unpaired data was used
to test for differences between males and females, and a Chi-
square test was used to test for a difference in percentage
distribution in categorical data, with a Pdiff ,0.05 considered
significant. Kolmogorov-Smirnov tests were performed to deter-
mine whether distributions for continuous variables followed
normal distributions, and if not then variables were transformed
accordingly.
Relative LTL measurements (T/S ratios) were log transformed
to achieve normality for use in sex-stratified analyses. LTL was
considered as the outcome variable, while age and BMI at AR;
WHR, BMI, BAI in adulthood and the BMI z-score change were
considered as predictor variables. Two models were tested: 1) an
unadjusted model, testing for association between log-transformed
LTL and adiposity-related measurements from childhood and
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adulthood; 2) an adjusted model, testing for association between
log-transformed LTL and adiposity-related measurements from
childhood and adulthood, controlling for potential confounders
known to be associated with either the outcome or predictor
variables. Those selected were maternal parity and SES at birth
(or paternal SES at birth if maternal SES was missing), and age at
menarche (females only), SES at 31 years, adulthood smoking and
number of children at 31 years. To control for possible batch
effects in the telomere measurements, all analyses were also
adjusted for qPCR plate. Estimated effects and 95% confidence
intervals are reported as % change in LTL per unit change in
predictor variable. The Benjamini and Hochberg method was
used to address the issue of multiple testing [35], with an adjusted
P value (Pcorrected) of ,0.05 considered statistically significant. All
statistical analyses were performed using SAS, version 9 (SAS
Institute Inc., SAS Campus Drive, Cary, North Carolina 27513,
USA).
Results
Cohort Characteristics
Table 1 shows the descriptive statistics for measures of
adiposity, LTL and potential confounding variables, for the study
population overall and stratified by sex. Consistent with other
human population studies [36], we observed a positive association
between telomere length and female gender, with men having a
mean T/S ratio of 1.12 and women a value of 1.17 (P,0.001).
Association between Childhood Growth and Adiposity
Measures and LTL at Age 31
BMI at AR was positively associated with LTL at 31 years in
females in unadjusted analyses (P = 0.007), and after adjusting for
potential confounding factors and correcting for multiple testing
(Pcorrected = 0.041). There was no association between BMI at AR
and LTL at 31 years in males (Table 2). There was no evidence
for an association between age at AR and LTL at 31 years in
either males or females, in unadjusted analyses (Model 1) and after
adjusting for potential confounding factors (maternal parity, SES
at birth, smoking, SES and having children at 31 years, and
additionally, in females only, age at menarche) (Model 2).
Association between Adulthood Adiposity-related
Phenotypes and LTL at Age 31
In the unadjusted Model 1, WHR was inversely associated with
LTL at 31 years in both males (P = 0.014) and females (P,0.001).
After adjustment for potential confounders (maternal parity and
SES at birth, age at menarche (female participants), SES, smoking
and number of children at 31 years) and correction for multiple
testing (Model 2), the association remained significant in females
(Pcorrected = 0.008) and males (Pcorrected = 0.049). An inverse
association between BMI and LTL at 31 years was also observed
in both males (P = 0.002) and females (P = 0.005), which remained
significant in males (Pcorrected = 0.025) and females (Pcorrected = 0.029)
after adjustment for potential confounders and correction for
multiple testing (Model 2). Body fat percentage, estimated by BAI
at age 31 was also inversely associated with LTL in females
(P = 0.004) and remained significant after adjustments
(Pcorrected = 0.021). However, BAI was not associated with LTL in
males (Table 2).
Association between BMI z-score Change from
Childhood-adulthood and LTL at 31
BMI z-score change from AR in childhood (at around 5 years) to
31 years was inversely associated with LTL at 31 years in females
(P,0.001) but not males (P = 0.238) (Model 1). A one unit increase
in BMI z-score change was associated with a 3.08% decrease in
LTL in females (Model 1), which reduced slightly to 2.91% after
adjustment for potential confounding factors (Pcorrected = 0.008).
Discussion
We have shown in a large population-based cohort that a
greater increase in standardised BMI from early childhood to
adulthood is associated with shorter mean relative LTL in women
aged 31. We have also shown that BMI and WHR at age 31 are
inversely associated with adult LTL in both men and women in
this study, and that higher BAI is inversely associated with LTL in
women only. All these associations remain significant after
adjusting for multiple potential confounders (maternal parity and
SES at birth, and age at menarche (females only), SES, smoking
and number of children at 31 years) and correcting for multiple
testing. Our results thus confirm and extend those reported in a
recent meta-analysis of BMI and LTL [23].
Our finding that WHR and BMI are both associated with LTL
in adult women is consistent with previous reports of an inverse
relationship between measures of adiposity and concurrent
telomere length [8,16,19,20,37]. In contrast to Nordfjall et al
[37], we found that BMI is associated with shorter telomeres in
adult men as well as in women. In addition, we identified an
inverse association between WHR and LTL in adult men, which is
consistent with a previous report that WHR is a significant
predictor of faster telomere shortening rate in a predominantly
male cohort (.80%) [17]. To our knowledge, our study is the first
to show that LTL is also inversely associated with BAI in women.
We did not see any evidence for an association between BAI and
LTL in men, perhaps because BAI may be more strongly
correlated with percentage of body fat in women than in men [38].
The gender difference for our main finding - that a greater
increase in standardised BMI from childhood to 31 years is
associated with shorter adult LTL - may reflect the fact that a
greater proportion of change in BMI in women compared to men
over this period is characterised by increased body fat [39]. This
association remains significant even after adjusting for number of
children born to participants by age 31 years, suggesting that this
finding is unrelated to pregnancy.
We did not find any evidence for an association between age at
adiposity rebound (AR) and LTL at age 31 in either sex, despite
previous studies in this cohort and others showing that earlier age
at AR predicts higher BMI and poorer metabolic health in
adulthood [28,40]. Intriguingly, we identified a positive association
between BMI at AR and adult telomere length in women, which
remained significant after correcting for maternal parity and SES
at birth, and age at menarche, SES, smoking status and number of
children at 31 years. Furthermore, there is no evidence of
association between BMI at AR and cardiometabolic profiles at
age 31 in this cohort [40]. We speculate that these findings may
reflect a beneficial effect of having a childhood BMI within the
normal range (as did the majority of participants in this population
cohort) on adult telomere length and metabolic health. Further
longitudinal studies of growth throughout childhood, weight gain
in adulthood and telomere measurements taken at multiple time
points are required to elucidate the mechanisms underlying these
observations.
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The major strengths of our study include the uniform age and
ethnicity of the participants, the even sex ratio and the availability
of LTL data for a large number of samples. Although concerns
have previously been expressed over the reliability of the qPCR
method [34], the telomere measurements used in this study show
the expected sex difference, and have previously been used in the
identification of robust genetic associations with LTL [4].
Additionally, the use of growth modelling phenotypes allowed
the investigation of the relationship between important measure-
ments of childhood adiposity and LTL in adulthood.
Due to the availability of DNA samples for only one time-point,
it was not possible to study the association between longitudinal
telomere length change and BMI trajectories over the same
period. Thus, we were unable to draw any conclusions regarding
causality for the relationship between BMI increase and telomere
length. We were also unable to study the potential effects of
interim changes in BMI between childhood and adulthood.
Finally, it would have been interesting to further investigate the
effects of underweight and obesity in childhood and adulthood on
adult LTL, but we did not have sufficient numbers of such
individuals available in this population cohort.
Despite these limitations, our study adds to the growing
evidence supporting the hypothesis that factors associated with
obesity, such as increased systemic levels of oxidative stress and/or
inflammation, may have similar effects on lifespan and cellular
function to the ageing process [41]. Our findings warrant further
investigation of the potential for using telomere length as a
biomarker to assess the effectiveness of interventions to combat the
negative impact of obesity on healthy ageing. These include
increased moderate physical activity, which has been associated
with longer telomeres (reviewed in [42]), as have dietary and
holistic weight loss interventions [43,44].
Conclusion
We show that LTL is inversely associated with multiple
measures of adiposity in both men and women, and that BMI
increase in women from childhood to adulthood is associated with
shorter telomeres at age 31. Further longitudinal studies are now
required to investigate the long-term effects of weight gain after
childhood on LTL, healthy ageing and disease risk, and to
investigate the gender differences observed.
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